Cntx stock

Published by elog tdpjq
29/05/2023

Cntx stock May 25, 2023 · The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79. Aug 2, 2022 · CNTX stock gained 5.8% to $2 in premarket trading. Now Read: Context Therapeutics GAAP EPS of -$0.40 misses by $0.21; Share Print Comment. Recommended For You. Exxon Mobil: $75 Oil Won't Last Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers bar View the latest Context Therapeutics Inc. (CNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.25mpfosimply indian restaurant Founded. 1970. PT Century Textile Industry Tbk engages in the integrated textile business. The firm activities include cloth spinning, weaving, dyeing, and finishing. Its products …The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79.The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around …Jun 6, 2022 · CNTX receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator. Context Therapeutics Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on CNTX! The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price …View the latest Context Therapeutics Inc. (CNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. smashed crab What's Happening with CNTX Stock Today. Context Therapeutics Inc (CNTX) stock has gained 55.2% while the S&P 500 has risen 1.03% as of 3:11 PM on Tuesday, Jan 31. CNTX has risen $0.38 from the previous closing price of $0.68 on volume of 72,149,168 shares. Over the past year the S&P 500 has fallen -10.11% while CNTX is lower by -48.04%.CNTX receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator. Context Therapeutics Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on CNTX!Context Therapeutics (CNTX) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Context Therapeutics (CNTX) Stock Price & Analysis. Follow. 31 Followers. Portfolio. CNTX Stock Chart & Stats. Advanced Chart > 1d 5d 3m 6m YTD 1y 3y 5y. Day’s Range $0 ...Current Stock Price for Context Therapeutics (CNTX)? A. The stock price for Context Therapeutics ( NASDAQ: CNTX) is $ 0.542 last updated May 12, 2023 at 7:59 PM UTC. Q.Oct 29, 2020 · A Pain-Focused Pipeline. Our pipeline consists of novel, non-opioid therapies that are in development to potentially treat a broad array of chronic pain indications. We believe that our pipeline is uniquely positioned to address the limitations of currently-available therapies by providing safe, effective and durable pain treatment solutions. Feb 24, 2023 · How much insider buying is happening at Context Therapeutics? Insiders have purchased a total of 107,118 CNTX shares in the last 24 months for a total of $184,029.74 bought. This page (NASDAQ:CNTX) was last updated on 2/24/2023 by MarketBeat.com Staff. Context Therapeutics Reports First Quarter 2023 Operating and Financial Results May 10, 2023TipRanks. H.C. Wainwright Remains a Hold on Context Therapeutics (CNTX) April 18, 2023TipRanks. SYMBOL. shiba stock price Dr D CNTX stock SEC Form 4 insiders trading. Dr has made over 1 trades of the Centrexion Therapeutics stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of CNTX stock worth $19,500 on 16 August 2022.Oct 29, 2020 · A Pain-Focused Pipeline. Our pipeline consists of novel, non-opioid therapies that are in development to potentially treat a broad array of chronic pain indications. We believe that our pipeline is uniquely positioned to address the limitations of currently-available therapies by providing safe, effective and durable pain treatment solutions. Context Therapeutics stock was originally listed at a price of $5.10 in Oct 20, 2021. If you had invested in Context Therapeutics stock at $5.10, your return over the last 1 years would have been -87.25%, for an annualized return of -87.25% (not including any dividends or dividend reinvestments).Feb 24, 2023 · How much insider buying is happening at Context Therapeutics? Insiders have purchased a total of 107,118 CNTX shares in the last 24 months for a total of $184,029.74 bought. This page (NASDAQ:CNTX) was last updated on 2/24/2023 by MarketBeat.com Staff. Context Therapeutics ( NASDAQ: CNTX) has filed to raise $19.5 million in an IPO of its common stock, according to an S-1/A registration statement. The firm is a clinical stage biopharma developing ... dis earnings date Find the latest PT Century Textile Industry Tbk (CNTX.JK) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Context Therapeutics Inc. (CNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.CNTX : 0.5841 (-4.25%) Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022 Globe Newswire - Tue Mar 8, 2022. Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m. ET... A Pain-Focused Pipeline. Our pipeline consists of novel, non-opioid therapies that are in development to potentially treat a broad array of chronic pain indications. We believe that our pipeline is uniquely positioned to address the limitations of currently-available therapies by providing safe, effective and durable pain treatment solutions.Mar 10, 2023 · Latest Context Therapeutics Inc Stock News. As of February 27, 2023, Context Therapeutics Inc had a $12.3 million market capitalization, putting it in the 12th percentile of companies in the Biotechnology & Medical Research industry. Context Therapeutics Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. cluckers menu At quarter-end, CNTX stock had $419,152 in cash and equivalents. With this in mind, the company spent 739,598 on R&D, while spending $828,464 on general expenses. All in all, the company posted a net loss of $1.4 million in Q3. Other CNTX Stock Developments. Context Therapeutics is making great strides in getting its product to the market.A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 ...Mar 24, 2023 · 2001 MARKET STREET, UNIT NO 15 SUITE 3915, PHILADELPHIA, Pennsylvania, 19103, United States +1 267 225-7416 https://www.contexttherapeutics.com. Context Therapeutics Inc is a clinical-stage ... Cntx stock has gained a lot of interest in the past two weeks due to the recent events surrounding the Cntx acquisition by the Carlyle Group.You can buy and sell Context Therapeutics (CNTX) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.Discover historical prices for CNTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Context Therapeutics Inc. stock was issued. Get the latest Context Therapeutics Inc. (CNTX) stock news and headlines to help you in your trading and investing decisions. comcast stock price today Jun 6, 2022 · CNTX receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator. Context Therapeutics Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on CNTX! The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79.2 days ago · Investing Peter Lynch Draws on 50 Years of Stock-Picking to Find Growth Opportunities in Today’s Market Dec. 20, 2019 at 11:48 p.m. ET by Barron's. Corrected Fear of ... View the latest Context Therapeutics Inc. (CNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Jan 31, 2023 · What's Happening with CNTX Stock Today. Context Therapeutics Inc (CNTX) stock has gained 55.2% while the S&P 500 has risen 1.03% as of 3:11 PM on Tuesday, Jan 31. CNTX has risen $0.38 from the previous closing price of $0.68 on volume of 72,149,168 shares. Over the past year the S&P 500 has fallen -10.11% while CNTX is lower by -48.04%. You can buy and sell Context Therapeutics (CNTX) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. CNTX : 0.5841 (-4.25%) Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022 Globe Newswire - Tue Mar 8, 2022. Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m. ET... 10 speed coffee santa monica tropical treats The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79. goodies carryoutCNTX : 0.5841 (-4.25%) Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022 Globe Newswire - Tue Mar 8, 2022. Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m. ET...Cntx stock has gained a lot of interest in the past two weeks due to the recent events surrounding the Cntx acquisition by the Carlyle Group.A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 ...May 25, 2023 · The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79. giannos of high point $CNTX Context Therapeutics Inc. stock float: N/A, short interest: 0.80% on Yahoo Finance, 15.04M and 0.79% on Finviz. Check more with @FloatChecker When possible will generally invest in component stocks of the Index in proportion to their Index weightings. Distribution History. Date Income Distribution; YTD-2022: $0.82: 2021: $0.57: 2020: $0.42:May 2, 2023 · Complete Context Therapeutics Inc. stock information by Barron's. View real-time CNTX stock price and news, along with industry-best analysis. Jan 31, 2023 · What's Happening with CNTX Stock Today. Context Therapeutics Inc (CNTX) stock has gained 55.2% while the S&P 500 has risen 1.03% as of 3:11 PM on Tuesday, Jan 31. CNTX has risen $0.38 from the previous closing price of $0.68 on volume of 72,149,168 shares. Over the past year the S&P 500 has fallen -10.11% while CNTX is lower by -48.04%. Jan 31, 2023 · What's Happening with CNTX Stock Today. Context Therapeutics Inc (CNTX) stock has gained 55.2% while the S&P 500 has risen 1.03% as of 3:11 PM on Tuesday, Jan 31. CNTX has risen $0.38 from the previous closing price of $0.68 on volume of 72,149,168 shares. Over the past year the S&P 500 has fallen -10.11% while CNTX is lower by -48.04%. $CNTX Context Therapeutics Inc. stock float: N/A, short interest: 0.80% on Yahoo Finance, 15.04M and 0.79% on Finviz. Check more with @FloatCheckerOct 29, 2020 · A Pain-Focused Pipeline. Our pipeline consists of novel, non-opioid therapies that are in development to potentially treat a broad array of chronic pain indications. We believe that our pipeline is uniquely positioned to address the limitations of currently-available therapies by providing safe, effective and durable pain treatment solutions. Context Therapeutics Reports First Quarter 2023 Operating and Financial Results May 10, 2023TipRanks. H.C. Wainwright Remains a Hold on Context Therapeutics (CNTX) April 18, 2023TipRanks. SYMBOL.You can buy and sell Context Therapeutics (CNTX) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. thai fried rice near meThe stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price …Discover historical prices for CNTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Context Therapeutics Inc. stock was issued.View the latest Context Therapeutics Inc. (CNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.CNTX-6016 is a cannabinoid agonist that has been shown in preclinical studies to be more than 16,000-fold selective for CB2 over CB1, with potential indications including diabetic and autoimmune neuropathic pain and chemotherapy-induced neuropathy. Human Osteoarthritis Pain CNTX-4975 ... jpm premarket 2001 MARKET STREET, UNIT NO 15 SUITE 3915, PHILADELPHIA, Pennsylvania, 19103, United States +1 267 225-7416 https://www.contexttherapeutics.com. Context Therapeutics Inc is a clinical-stage ...May 25, 2023 · The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79. What's Happening with CNTX Stock Today. Context Therapeutics Inc (CNTX) stock has gained 55.2% while the S&P 500 has risen 1.03% as of 3:11 PM on Tuesday, Jan 31. CNTX has risen $0.38 from the previous closing price of $0.68 on volume of 72,149,168 shares. Over the past year the S&P 500 has fallen -10.11% while CNTX is lower by -48.04%.Dec 9, 2021 · Context Therapeutics Inc. (Nasdaq: CNTX), is a women’s oncology company developing small molecule and immunotherapy treatments to transform care for breast and gynecological cancers. View live Context Therapeutics Inc chart to track its stock's price action. Find market predictions, CNTX financials and market news.16:00 EST CNTX Stock Quote Delayed 30 Minutes Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday. By William White, InvestorPlace Writer Apr 4, 2022Jul 2, 2021 · Context Therapeutics ( NASDAQ: CNTX) has filed to raise $19.5 million in an IPO of its common stock, according to an S-1/A registration statement. The firm is a clinical stage biopharma developing ... May 25, 2023 · The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79. Find the latest Context Therapeutics Inc. (CNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.CNTX’s beta can be found in Trading Information at the top of this page. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.Founded. 1970. PT Century Textile Industry Tbk engages in the integrated textile business. The firm activities include cloth spinning, weaving, dyeing, and finishing. Its products include plain and dobby tetoron cotton, chief value cotton, and oxford fabrics. The company was founded on May 22, 1970 and is headquartered in Jakarta, Indonesia.Find the latest Context Therapeutics Inc. (CNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Context Therapeutics (CNTX) last ex-dividend date was on ―. Context Therapeutics distributed ― per share that represents a ― dividend yield. ... Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts. Compare More Stocks > FAQ.CNTX Context Therapeutics Inc Context Therapeutics and Lonza Enter Manufacturing Agreement for Bispecific Antibody Targeting Claudin 6-Positive Cancers Lonza to support the development and manufacturing of CTIM-76, Context's CLDN6 x CD3 bispecific antibody clinical candidate The bispecific antibody-based therapy is being developed to redirect T ... bagel sandwich near me You can buy and sell Context Therapeutics (CNTX) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.Jul 2, 2021 · Context Therapeutics ( NASDAQ: CNTX) has filed to raise $19.5 million in an IPO of its common stock, according to an S-1/A registration statement. The firm is a clinical stage biopharma developing ... View the latest Context Therapeutics Inc. (CNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. doodash taste of flavors carlucci's expressCNTX : 0.5841 (-4.25%) Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022 Globe Newswire - Tue Mar 8, 2022. Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m. ET... Find the latest PT Century Textile Industry Tbk (CNTX.JK) stock quote, history, news and other vital information to help you with your stock trading and investing. Cntx stock has gained a lot of interest in the past two weeks due to the recent events surrounding the Cntx acquisition by the Carlyle Group.Get the latest Context Therapeutics Inc (CNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Webull offers kinds of Context Therapeutics Inc stock information, including NASDAQ:CNTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNTX stock news, and many more online research tools to help you make informed decisions. You can practice and explore trading CNTX stock …PT Century Textile Industry Tbk (CNTX.JK) Jakarta - Jakarta Delayed Price. Currency in IDR. Follow. 246.00 -2.00 (-0.81%) At close: 09:07AM WIB. 1d. 5d. 1m. mi morelia $CNTX Context Therapeutics Inc. stock float: N/A, short interest: 0.80% on Yahoo Finance, 15.04M and 0.79% on Finviz. Check more with @FloatChecker Find the latest PT Century Textile Industry Tbk (CNTX.JK) stock quote, history, news and other vital information to help you with your stock trading and investing.$CNTX Context Therapeutics Inc. stock float: N/A, short interest: 0.80% on Yahoo Finance, 15.04M and 0.79% on Finviz. Check more with @FloatChecker route 24 ale house When possible will generally invest in component stocks of the Index in proportion to their Index weightings. Distribution History. Date Income Distribution; YTD-2022: $0.82: 2021: $0.57: 2020: $0.42:The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79.$CNTX Context Therapeutics Inc. stock float: N/A, short interest: 0.80% on Yahoo Finance, 15.04M and 0.79% on Finviz. Check more with @FloatChecker jalapenos taco shop Founded. 1970. PT Century Textile Industry Tbk engages in the integrated textile business. The firm activities include cloth spinning, weaving, dyeing, and finishing. Its products include plain and dobby tetoron cotton, chief value cotton, and oxford fabrics. The company was founded on May 22, 1970 and is headquartered in Jakarta, Indonesia.The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79.2001 MARKET STREET, UNIT NO 15 SUITE 3915, PHILADELPHIA, Pennsylvania, 19103, United States +1 267 225-7416 https://www.contexttherapeutics.com. Context Therapeutics Inc is a clinical-stage ... bommarillu maple tree bbqContext Therapeutics stock was originally listed at a price of $5.10 in Oct 20, 2021. If you had invested in Context Therapeutics stock at $5.10, your return over the last 1 years would have been -87.25%, for an annualized return of -87.25% (not including any dividends or dividend reinvestments). joby stock price View the latest Context Therapeutics Inc. (CNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.May 25, 2023 · The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79. park avenue bbq grille What's Happening with CNTX Stock Today. Context Therapeutics Inc (CNTX) stock has gained 55.2% while the S&P 500 has risen 1.03% as of 3:11 PM on Tuesday, Jan 31. CNTX has risen $0.38 from the previous closing price of $0.68 on volume of 72,149,168 shares. Over the past year the S&P 500 has fallen -10.11% while CNTX is lower by -48.04%.Context Therapeutics stock was originally listed at a price of $5.10 in Oct 20, 2021. If you had invested in Context Therapeutics stock at $5.10, your return over the last 1 years would have been -87.25%, for an annualized return of -87.25% (not including any dividends or dividend reinvestments). Webull offers kinds of Context Therapeutics Inc stock information, including NASDAQ:CNTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNTX stock news, and many more online research tools to help you make informed decisions. You can practice and explore trading CNTX stock … jamba juice order online May 25, 2023 · The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79. CNTX receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator. Context Therapeutics Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on CNTX!Context Therapeutics Inc. Common Stock (CNTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.View Context Therapeutics Inc CNTX investment & stock information. Get the latest Context Therapeutics Inc CNTX detailed stock quotes, stock data, Real-Time … nyse nvta CNTX receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator. Context Therapeutics Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on CNTX!How much insider buying is happening at Context Therapeutics? Insiders have purchased a total of 107,118 CNTX shares in the last 24 months for a total of $184,029.74 bought. This page (NASDAQ:CNTX) was last updated on 2/24/2023 by MarketBeat.com Staff.CNTX : 0.5841 (-4.25%) Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022 Globe Newswire - Tue Mar 8, 2022. Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m. ET...May 25, 2023 · The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79. What's Happening with CNTX Stock Today. Context Therapeutics Inc (CNTX) stock has gained 55.2% while the S&P 500 has risen 1.03% as of 3:11 PM on Tuesday, Jan 31. CNTX has risen $0.38 from the previous closing price of $0.68 on volume of 72,149,168 shares. Over the past year the S&P 500 has fallen -10.11% while CNTX is lower by -48.04%.What's Happening with CNTX Stock Today. Context Therapeutics Inc (CNTX) stock has gained 55.2% while the S&P 500 has risen 1.03% as of 3:11 PM on Tuesday, Jan 31. CNTX has risen $0.38 from the previous closing price of $0.68 on volume of 72,149,168 shares. Over the past year the S&P 500 has fallen -10.11% while CNTX is lower by -48.04%. johal chaat and curry You can buy and sell Context Therapeutics (CNTX) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.Discover historical prices for CNTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Context Therapeutics Inc. stock was issued. A Pain-Focused Pipeline. Our pipeline consists of novel, non-opioid therapies that are in development to potentially treat a broad array of chronic pain indications. We believe that our pipeline is uniquely positioned to address the limitations of currently-available therapies by providing safe, effective and durable pain treatment solutions.CNTX Earnings Forecast. Next quarter’s earnings estimate for CNTX is -$0.19 with a range of -$0.22 to -$0.16. The previous quarter’s EPS was -$0.22. CNTX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.73% of the time in the same period. In the last calendar year CNTX has ... mister oso In the past week, CNTX stock has gone up by 44.64%, with a monthly gain of 36.99% and a quarterly plunge of -0.39%. The volatility ratio for the week is 18.04%, …The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price … octopus near me clearwater oyster bar and grillDiscover historical prices for CNTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Context Therapeutics Inc. stock was issued.$CNTX Context Therapeutics Inc. stock float: N/A, short interest: 0.80% on Yahoo Finance, 15.04M and 0.79% on Finviz. Check more with @FloatCheckerCurrent Stock Price for Context Therapeutics (CNTX)? A. The stock price for Context Therapeutics ( NASDAQ: CNTX) is $ 0.542 last updated May 12, 2023 at 7:59 PM UTC. Q. british currency CNTX stock is up 9% as of Friday morning and is up 33.7% since the start of the year. Investors on the lookout for more recent stock market news don’t have to search far.CNTX receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator. Context Therapeutics Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on CNTX! plataformas de mujer$CNTX Context Therapeutics Inc. stock float: N/A, short interest: 0.80% on Yahoo Finance, 15.04M and 0.79% on Finviz. Check more with @FloatCheckerGet the latest Context Therapeutics Inc. (CNTX) stock news and headlines to help you in your trading and investing decisions.How much insider buying is happening at Context Therapeutics? Insiders have purchased a total of 107,118 CNTX shares in the last 24 months for a total of $184,029.74 bought. This page (NASDAQ:CNTX) was last updated on 2/24/2023 by MarketBeat.com Staff.According to analyst projections, CNTX’s forecast low is $4.00 with $4.00 as the target high. To hit the forecast high, the stock’s price needs a -236.13% plunge from its current level, while the stock would need to soar -236.13% for it to hit the projected low. Context Therapeutics Inc. (CNTX) estimates and forecasts cafe june CNTX Earnings Forecast. Next quarter’s earnings estimate for CNTX is -$0.19 with a range of -$0.22 to -$0.16. The previous quarter’s EPS was -$0.22. CNTX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.73% of the time in the same period. In the last calendar year CNTX has ...What's Happening with CNTX Stock Today. Context Therapeutics Inc (CNTX) stock has gained 55.2% while the S&P 500 has risen 1.03% as of 3:11 PM on Tuesday, Jan 31. CNTX has risen $0.38 from the previous closing price of $0.68 on volume of 72,149,168 shares. Over the past year the S&P 500 has fallen -10.11% while CNTX is lower by -48.04%.You can buy and sell Context Therapeutics (CNTX) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details.Get the latest Context Therapeutics Inc. (CNTX) stock news and headlines to help you in your trading and investing decisions.A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 ... ice cream close to me Latest Context Therapeutics Inc Stock News. As of February 27, 2023, Context Therapeutics Inc had a $12.3 million market capitalization, putting it in the 12th percentile of companies in the Biotechnology & Medical Research industry. Context Therapeutics Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months.Get a real-time Context Therapeutics Inc. (CNTX) stock price quote with breaking news, financials, statistics, charts and more.Apr 4, 2022 · 16:00 EST CNTX Stock Quote Delayed 30 Minutes Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday. By William White, InvestorPlace Writer Apr 4, 2022 cop stock price today CNTX stock gained 5.8% to $2 in premarket trading. Now Read: Context Therapeutics GAAP EPS of -$0.40 misses by $0.21; Share Print Comment. Recommended For You. Exxon Mobil: $75 Oil Won't LastMay 25, 2023 · The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79. restaurant near me takeout May 22, 2023 · CNTX | Complete Context Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. What's Happening with CNTX Stock Today. Context Therapeutics Inc (CNTX) stock has gained 55.2% while the S&P 500 has risen 1.03% as of 3:11 PM on Tuesday, Jan 31. CNTX has risen $0.38 from the previous closing price of $0.68 on volume of 72,149,168 shares. Over the past year the S&P 500 has fallen -10.11% while CNTX is lower by -48.04%.A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 ... taste of flava Current Stock Price for Context Therapeutics (CNTX)? A. The stock price for Context Therapeutics ( NASDAQ: CNTX) is $ 0.542 last updated May 12, 2023 at 7:59 PM UTC. Q.Oct 29, 2020 · A Pain-Focused Pipeline. Our pipeline consists of novel, non-opioid therapies that are in development to potentially treat a broad array of chronic pain indications. We believe that our pipeline is uniquely positioned to address the limitations of currently-available therapies by providing safe, effective and durable pain treatment solutions. The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79.Mar 24, 2023 · 2001 MARKET STREET, UNIT NO 15 SUITE 3915, PHILADELPHIA, Pennsylvania, 19103, United States +1 267 225-7416 https://www.contexttherapeutics.com. Context Therapeutics Inc is a clinical-stage ... sweet cat cafeContext Therapeutics Inc. Common Stock (CNTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.You can buy and sell Context Therapeutics (CNTX) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. ni price taqueria datapointFind the latest Context Therapeutics Inc. (CNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.The stock’s price range for this time frame has been between $0.47 and $2.52. The trading volume of the company’s shares in the Healthcare reached around 0.9 million for the day, which was evidently higher than the average daily volume of 94970.0 over the last three months. Context Therapeutics Inc. (CNTX) currently has a stock price of $0.79.CNTX : 0.5841 (-4.25%) Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022 Globe Newswire - Tue Mar 8, 2022. Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m. ET... PT Century Textile Industry Tbk (CNTX.JK) Jakarta - Jakarta Delayed Price. Currency in IDR. Follow. 246.00 -2.00 (-0.81%) At close: 09:07AM WIB. 1d. 5d. 1m. two guys pizzeria Founded. 1970. PT Century Textile Industry Tbk engages in the integrated textile business. The firm activities include cloth spinning, weaving, dyeing, and finishing. Its products include plain and dobby tetoron cotton, chief value cotton, and oxford fabrics. The company was founded on May 22, 1970 and is headquartered in Jakarta, Indonesia.Mar 24, 2023 · 2001 MARKET STREET, UNIT NO 15 SUITE 3915, PHILADELPHIA, Pennsylvania, 19103, United States +1 267 225-7416 https://www.contexttherapeutics.com. Context Therapeutics Inc is a clinical-stage ... When possible will generally invest in component stocks of the Index in proportion to their Index weightings. Distribution History. Date Income Distribution; YTD-2022: $0.82: 2021: $0.57: 2020: $0.42:Get a real-time Context Therapeutics Inc. (CNTX) stock price quote with breaking news, financials, statistics, charts and more.Aug 17, 2022 · Dr D CNTX stock SEC Form 4 insiders trading. Dr has made over 1 trades of the Centrexion Therapeutics stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of CNTX stock worth $19,500 on 16 August 2022. Feb 24, 2023 · How much insider buying is happening at Context Therapeutics? Insiders have purchased a total of 107,118 CNTX shares in the last 24 months for a total of $184,029.74 bought. This page (NASDAQ:CNTX) was last updated on 2/24/2023 by MarketBeat.com Staff. CNTX stock is up 9% as of Friday morning and is up 33.7% since the start of the year. Investors on the lookout for more recent stock market news don’t have to search far.Context Therapeutics® Announces Pricing of Initial Public Offering. (GlobeNewswire) Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors in the United States. It develops CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell ...